Health Affairs, 24, no. 4 (2005): 938-948 doi: 10.1377/hlthaff.24.4.938 © 2005 by Project HOPE	New Online   How Would Obama, McCain Cover The Uninsured?   Debating Cost Of Uninsured   Try Medicare-For-All   HA Blog Top 10

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Gottlieb, S. Search for Related Content PubMed PubMed Citation Articles by Gottlieb, S. Related Collections Business Of Health Consumer Issues Legal/Regulatory Issues Quality Of Care Research And Technology Politics

FDA Under Scrutiny

Opening Pandora’s Pillbox: Using Modern Information Tools To Improve Drug Safety

How the Food and Drug Administration (FDA) responds to criticism of its drug safety process will determine whether drug safety actually improves. Propping up the Office of Drug Safety with more bureaucratic prominence or adding new requirements to the preapproval process will add to the cost of drug development and not make drugs safer. New information tools can dramatically improve postmarketing surveillance and collection of data on safety. This information could then be used to reach more definitive regulatory conclusions sooner. New incentives will be needed to entice payers and product developers to work on building a broader, more robust system for collecting data on drug safety.

                      What's this?

This article has been cited by other articles:

				R. Platt and A. Ommaya A Beneficial Side Effect of the Medicare Drug Benefit N. Engl. J. Med., December 29, 2005; 353(26): 2742 - 2743. [Full Text] [PDF]